PolitiFact @PolitiFact
Experts say it’s unlikely that “dozens” of pharmaceutical firms that aren’t already producing the vaccines stand ready to do so. Supplies, storage capacity, training and facility compliance are just some aspects that make the process complex and lengthy. https://t.co/ObZZoQXys5 — PolitiTweet.org